Skip to content

Role of Sthanika Panchamoola Kwatha Nadi Sweda with Guda Ardraka Nasya and Dashamoola Kwatha Nadi Sweda with Guda Ardraka Nasya in Manyastambha or Cervical Spondylosis.

A randomized open labelled clinical study on the efficacy Of Sthanika Panchamoola Kwatha Nadi Sweda in comparison with Sthanika Dashamoola Kwatha Nadi Sweda followed by Guda Ardraka Nasya in the management of Manyastambha Vis-A-vis Cervical Spondylosis. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102582
Enrollment
30
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

None listed

Sponsors

Dr Anushree H M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects with classical signs and symptoms of Manyastambha vis-a-vis Cervical spondylosis. 2. Subjects between the age group of 21-50 years. 3. Subjects of either gender irrespective of religion and socio-economic status. 4. Subjects fit for Avapeedana Nasya. 5. Subjects fit for Sthanika Nadi Sweda. 6. Subjects who are willing to give written consent and participate in the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women. 2. Subjects on concurrent medications. 3. Subjects with congenital deformity, traumatic injury, cervical stenosis and myelopathy, infections of bone and gross bony deformity and epistaxis. 4. Other systemic disorders which interfere in the line of treatment like uncontrolled diabetes, uncontrolled hypertension and cardiovascular diseases.

Design outcomes

Primary

MeasureTime frame
Significant reduction in Pain, stiffness and improvement in Cervical range of movements measured by VAS scale, Stiffness grading and goniometer readings respectively. Timepoint: Trial period: 7 days Assessment on: 0th day, 7th day, 14th day Follow up: 14th day Total study duration: 14 days

Secondary

MeasureTime frame
1. Generation of data on possible unexpected/adverse drug reactions or events. 2. Generation of data on quality of life with the test treatment modalities assessed based on Neck disability index. Timepoint: Trial period: 7 days Assessment on: 0th day, 7th day, 14th day Follow up: 14th day Total study duration: 14 days

Countries

India

Contacts

Public ContactDr Ganesh Puttur

Sri Sri College Of Ayurvedic Science and Research Hospital

drganeshputtur@gmail.com9538176059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026